Physician profile
Steven Clinger
NPI 1790722841
$471.98
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $358 · 2020: $114.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $74.95 | 2019-2020 | |
| Allergan, INC. | $66.14 | 2019-2020 | |
| Novo Nordisk INC | $61.10 | 2019-2020 | |
| Pfizer INC. | $41.62 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $37.10 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $36.26 | 2019 | |
| Amgen INC. | $35.05 | 2019 | |
| Glaxosmithkline, LLC. | $29.01 | 2019 | |
| Merck Sharp & Dohme LLC | $18.74 | 2019 | |
| Arbor Pharmaceuticals, INC. | $16.20 | 2020 | |
| Genentech USA, INC. | $15.78 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $14.37 | 2019 | |
| Lilly USA, LLC | $14.06 | 2019 | |
| Circassia INC. | $11.60 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Clinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.